Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Surgery Partners, Inc. (SGRY)

Surgery Partners to be acquired for $23.50 a share in cash, valued at $5.7 billion

Positive Impact 5 of 5 m&a Written later

Surgery Partners agreed on October 23, 2026 to be acquired by Spyglass Topco, LLC, an entity tied to HealthSpan Partners, in a deal the company values at about $5.7 billion enterprise value. Public shareholders other than Bain Capital affiliates would receive $23.50 in cash per share, and the company would become privately held and delist from Nasdaq if the deal closes. Completion depends on stockholder approval, regulatory clearance, and other customary conditions, with closing expected in the first quarter of 2027.

Key points

  • Per-share cash consideration of $23.50 for common stock, excluding Bain Capital rollover shares, appraisal shares and certain other holdings
  • Bain Capital affiliates, owning about 39% of outstanding shares, agreed to vote in favor and roll over their equity into the acquiring entity
  • Expected closing in the first quarter of 2027; either party may terminate if the merger is not completed by July 23, 2027, subject to extensions
  • Stockholder approval requires a majority of outstanding shares and a majority of votes cast by disinterested stockholders

The filing

CompanySurgery Partners, Inc. (SGRY)
Form8-K, current report
Filed with the SECOct 26, 2026, 9:03 AM ET
Accession number0001104659-26-118643

Items reported: 1.01 Material Definitive Agreement7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 26, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.